quinapril has been researched along with Cerebrovascular Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, K; Horizoe, H; Ikegami, K; Nakajima, T; Nakamura, I; Okuda, K; Setoguchi, M; Tomitaka, Y; Yamada, T; Yaoka, O | 1 |
| Bruneval, P; Domergue, V; Fornes, P; Giudicelli, JF; Richer, C; Vacher, E | 1 |
2 other study(ies) available for quinapril and Cerebrovascular Disorders
| Article | Year |
|---|---|
[Effects of quinapril on the development of hypertension, cardiac hypertrophy and stroke in salt-sensitive Dahl rats and stroke-prone spontaneously hypertensive rats].
Topics: Animals; Body Weight; Cardiomegaly; Cerebrovascular Disorders; Heart; Heart Rate; Hypertension; Isoquinolines; Male; Organ Size; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Sodium Chloride; Tetrahydroisoquinolines | 1993 |
Quinapril prevents stroke both during and after the treatment period in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Height; Body Weight; Brain; Cerebrovascular Disorders; Diuresis; Heart Rate; Hypertension; Incidence; Isoquinolines; Kidney; Male; Myocardium; Proteinuria; Quinapril; Rats; Rats, Inbred SHR; Risk Factors; Tetrahydroisoquinolines; Time Factors | 1993 |